Skip to content

The Effectiveness of Multi-Berry Juice in the Treatment of Eczema and Acne Using Pre Post Methodology

Does drinking a multi-berry, anti-oxidant juice improve the symptoms of patients with eczema and acne comparing pre and post treatment?

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611000220965
Enrollment
96
Registered
2011-02-28
Start date
2011-06-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A significant body of research has been dedicated to addressing the antioxidant activity associated with consuming berries and other foods. Studies have purported the anti-inflammatory and anti-microbial activity of these berries and foods. Multi-berry juices have emerged trying to combine concentrated amounts of various berries in attempt to maximize the antioxidant properties. Traditionally, berries and multi-berry drinks have been used as home remedies to improve such conditions as skin rashes and bowel disorders. However, there are only a small number of studies that address the clinical benefits of multi-berry drinks and even a smaller number of studies specifically addressing skin and bowel disorders. More and more patients are trying these antioxidant beverages. How do primary care physicians make sense of the research so that they can provide recommendations to these patients?

Interventions

This study will use a pre-post design to explore the possibility of an effect of berry juice on the severity of acne/eczema. The juice will be a Canadian-produced juice containing red raspberry, blueberry, blackberry, boysenberry, cranberry, blackcurrant, elderberry, fucoidan, bladderwrack, ulva, fructose, and potassium sorbate. Enrolled patients will be given a 2 week washout period prior to beginning their course of berry juice in order to ensure previous acne/eczema medications are absent fro

This study will use a pre-post design to explore the possibility of an effect of berry juice on the severity of acne/eczema. The juice will be a Canadian-produced juice containing red raspberry, blueberry, blackberry, boysenberry, cranberry, blackcurrant, elderberry, fucoidan, bladderwrack, ulva, fructose, and potassium sorbate. Enrolled patients will be given a 2 week washout period prior to beginning their course of berry juice in order to ensure previous acne/eczema medications are absent from the body. A baseline measure will be taken. Patients will be then be provided with a 6 week course of berry juice. They will drink 3oz of juice daily. At the end of the 6 weeks, severity of acne/eczema will be measured.

Sponsors

Lizette Elumir
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults (>= 18 years of age) with known diagnoses of eczema or acne. Patient may be new diagnoses not taking treatment; patients who are willing to go off standard treatment; or patients who have tried standard treatment with no success.

Exclusion criteria

Undiagnosed skin disorders – subjects need to have been diagnosed by a physician Patients for whom it would be prohibitively burdensome to not be treated with standard acne/eczema treatment. Known allergies to the contents of the juice – red raspberry, blueberry, blackberry, boysenberry, cranberry, blackcurrant, elderberry, fucoidan, bladderwrack, ulva, fructose, potassium sorbate Patients taking antibiotics, diuretics, blood thinners and theophylline – there are no clinical trials but just theoretical effects that the juice may have on these medications Because of the theoretical effects that the juice has on blood and kidneys, patients who have the following diagnoses are also excluded: Pregnancy, kidney failure, blood disorders, and cancer. Patients taking Diane 35 for acne

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026